Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
86478 trials found · Page 74 of 4324
-
Race against time: new hope for stroke patients misses early treatment window
Disease control CompletedThis study is designed to evaluate the efficacy of IV rhTNK-tPA between 4.5 to 24 hours from symptom onset in patients presenting with a non-large vessel occlusion ischemic stroke.
Phase: PHASE4 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Scientists test 'One-Time' gene fix for devastating childhood disease
Disease control OngoingMPS II is a genetic disorder that affects boys. Boys with MPS II are missing a working enzyme known as iduronate-2-sulfatase (IDS) which is needed to break down long sugar chains in the body. When this enzyme is missing, these sugars build up to excess causing damage, and stop or…
Phase: PHASE1, PHASE2 • Sponsor: University of Manchester • Aim: Disease control
Last updated Apr 20, 2026 16:17 UTC
-
New hope for Tough-to-Treat lung cancer: major trial tests promising drug
Disease control OngoingThe main objective is to compare the efficacy of tarlatamab with standard of care (SOC) on prolonging overall survival (OS).
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Hot chemo bath tested in major ovarian cancer trial
Disease control Recruiting nowPrimary stage III-IV epithelial ovarian cancer randomizing between interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC)
Phase: PHASE3 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Apr 13, 2026 20:08 UTC
-
New hope for kids with tough cancers: first test of 'Living Drug' therapy
Disease control Recruiting nowThis is a first in human dose escalation trial to determine the safety of administering GPC2 CAR T cells in patients with advanced neuroblastoma or retinoblastoma.
Phase: PHASE1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Apr 13, 2026 20:19 UTC
-
New hope for tough blood cancers: optimized transplant trial seeks better survival
Disease control Recruiting nowCord blood transplants (CBT) are a standard treatment for adults with blood cancers. MSK has developed a standard ("optimized") practice for cord blood transplant (CBT). This optimized practice includes how patients are evaluated for transplant, the conditioning treatment (standa…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 17, 2026 16:10 UTC
-
Voice box transplants offer new hope for those who lost their voice
Disease control TerminatedThe purpose of this proposed study is to obtain safety and efficacy data on human laryngeal allograft transplantation in an effort to safely use these procedures as a viable reconstructive option for patients with severe laryngeal or laryngotracheal incompetence.
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 09, 2026 19:34 UTC
-
New hope for kids with relapsed leukemia: targeted drug may beat standard chemo
Disease control Recruiting nowThis prospective, randomized, multicenter, open-label Phase 2 study is designed to evaluate the superiority of InO monotherapy vs ALLR3 after 1 cycle of induction treatment in paediatric participants (between 1 and \<18 years) with High Risk (HR) first bone marrow relapse CD22-po…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 25, 2026 17:15 UTC
-
New vaccine combo aims to supercharge immune system against HPV-Linked throat cancer
Disease control Recruiting nowThis phase II trial tests how well pB1-11 and human papillomavirus tumor antigen (TA-HPV) vaccines in combination with pembrolizumab work in treating patients with oropharyngeal cancer that has come back (recurrent) or that has spread from where it first started (primary site) to…
Phase: PHASE2 • Sponsor: Michael K. Gibson • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC
-
Could a simple pill stop long COVID before it starts?
Prevention OngoingThe goal of this clinical trial is to compare treatment with oral Paxlovid (nirmatrelvir/ritonavir) and placebo for acute COVID-19 as an intervention to prevent long-COVID (post-COVID-19 condition) in adults aged 18-64 years old. The main question it aims to answer is: Does tre…
Phase: PHASE3 • Sponsor: Haukeland University Hospital • Aim: Prevention
Last updated Apr 24, 2026 16:18 UTC
-
New drug shows promise for deadly lung pressure disease
Disease control CompletedThis local Phase 3 study is planned to confirm the efficacy and safety in Japanese PAH participants. The primary population of this study is Japanese PAH participants with World Health Organization Functional Class (WHO FC) II or III while the study includes PAH participants with…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 22, 2026 16:00 UTC
-
New Two-Pronged cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of rondecabtagene autoleucel (ronde-cel) also known as LYL314, a dual-targeting chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggress…
Phase: PHASE1, PHASE2 • Sponsor: Lyell Immunopharma, Inc. • Aim: Disease control
Last updated Apr 21, 2026 12:44 UTC
-
Vaccine aimed at stopping colon cancer in lynch syndrome patients shows promise
Prevention OngoingThis phase IIb trial tests whether Tri-Ad5 in combination with N-803 works to prevent colon and other cancers in participants with Lynch syndrome. Each of the three injections in Tri-Ad5 vaccine contain a different substance that is in precancer and cancer cells. Injecting these …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Apr 25, 2026 17:12 UTC
-
Quad-Target CAR t cells injected into brain show promise for childhood cancers
Disease control OngoingThis is a Phase 1 study of central nervous system (CNS) locoregional adoptive therapy with SC-CAR4BRAIN, an autologous CD4+ and CD8+ T cells lentivirally transduced to express to express combinations of B7-H3, EGFR806, HER2, and IL13-zetakine chimeric antigen receptors (CAR). CAR…
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Apr 25, 2026 17:13 UTC
-
New hope for Tough-to-Treat lung cancer: major trial tests promising drug combo
Disease control OngoingA Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112 or Placebo Combined With Pemetrexed and Carboplatin in Patients With EGFR-mutant Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer Who Have Progressed on or Following Growth Factor Re…
Phase: PHASE3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated Apr 09, 2026 19:34 UTC
-
Could a meningitis shot stop gonorrhea? major trial underway
Prevention OngoingObjectives: Efficacy of a meningococcal vaccine against Neisseria gonorrhoea (NG) infection among men who have sex with men (MSM). Design: Parallel randomised double-blind placebo-controlled trial. Setting: A teaching hospital in Hong Kong. Participants: 150 adult MSM at risk …
Phase: PHASE3 • Sponsor: Chinese University of Hong Kong • Aim: Prevention
Last updated Apr 17, 2026 16:10 UTC
-
Medical first: surgeons test robotic bladder transplants in humans
Disease control Recruiting nowThis phase 0 trial tests the feasibility, functionality, and sustainability of vascularized composite bladder allograft transplantation in treating patients with terminal bladder pathology. A vascularized bladder allograft transplantation may provide a more durable and better-tol…
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Apr 20, 2026 16:18 UTC
-
Massive typhoid vaccine trial in india shows promise against deadly fever
⭐️ VACCINE ⭐️ CompletedThis cluster randomised trial will examine the impact of introducing TyphiBEV, a typhoid conjugate vaccine licensed in India, on the incidence of typhoid fever in a high burden urban setting in South India.
Phase: PHASE4 • Sponsor: Christian Medical College, Vellore, India • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 25, 2026 17:13 UTC
-
New hope for veterans in crisis: can a special therapy group save lives?
Disease control OngoingVeteran suicide death is a national crisis. Risk factors include emotion dysregulation, which occurs across mental health disorders. Dialectical behavior therapy (DBT) is an evidence-based suicide intervention that targets emotion dysregulation but is resource-intensive and not w…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Experimental CAR t therapy takes aim at tough lupus kidney cases
Disease control OngoingA Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects With Refractory Lupus Nephritis
Phase: PHASE1, PHASE2 • Sponsor: Kyverna Therapeutics • Aim: Disease control
Last updated Apr 24, 2026 16:18 UTC